Joel M Gelfand

faculty photo
James J. Leyden, M.D. Endowed Professor in Clinical Investigation
Associate Fellow, Center for Public Health Initiatives, University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Director, Patient Centered Outcomes Research Track, Master of Science in Clinical Epidemiology Degree Program
Medical Director, Psoriasis and Phototherapy Treatment Center, Department of Dermatology, University of Pennsylvania
Endowed Professorship, James J. Leyden, M.D. Endowed Professorship in Clinical Investigation
Director, Center for Clinical Sciences in Dermatology
Department: Dermatology

Contact information
Perelman Center for Advanced Medicine
7th Floor, South Tower
Suite 730
Philadelphia, PA 19104
B.S. (Biology, Community Health)
Tufts University, 1993.
Harvard Medical School, 1998.
M.S.C.E. (Epidemiology)
University of Pennsylvania, 2003.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Other Expertise


Selected Publications

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, and Troxel AB: The risk of myocardial infarction in patients with psoriasis. Journal of the American Medical Association 296: 1735-1741, 2006.

Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, and Rolstad T: Epidemiology of Psoriatic Arthritis in the United States Population. Journal of the American Academy of Dermatology 53: 573-7, 2005.

Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, and Troxel AB: The risk of lymphoma in patients with psoriasis. Journal of Investigative Dermatology 126: 2194-2201, 2006.

Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, and Troxel AB: The Risk of Stroke in Patients with Psoriasis. Journal of Investigative Dermatology 129: 2411-2418, 2009.

Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, and Gelfand JM: Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using General Practice Research Database. European Heart Journal 31: 1000-06, 2010.

Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, and Gelfand JM. : The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Journal of the American Academy of Dermatology 64(6): 1035-1060, June 2011.

Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, and Gelfand JM: Systemic and Vascular Inflammation in Patients with Moderate to Severe Psoriasis as measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT): A Pilot Study. Archives of Dermatology 147(9): 1031-1039, September 2011.

Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, and Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: A population-based study in the United Kingdom. Journal of Investigative Dermatology Advance Online Publication, November 2011.

Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, and Van Voorhees AS: Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice Setting. Archives of Dermatology 148(4): 487-94, April 2012.

Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, and Gelfand JM: Increased Risk of Diabetes and Likelihood of Receiving Diabetes Treatment in Patients with Psoriasis. Archives of Dermatology 18: 1 - 6 Jun 2012.

Mehta NN, Torigian DA, Gelfand, JM, Saboury, B, and Alavi A: Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography (PET)/Computed Tomography (CT). Journal of Visualized Experiments 63: e3777, 2012.

Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, and Gelfand JM.: "Patient reported reasons for the discontinuation of commonly used treatments for moderate-to-severe psoriasis." Journal of American Academy of Dermatology 68: 64-72, 2013.

back to top
Last updated: 06/18/2024
The Trustees of the University of Pennsylvania